Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

951 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Glimepiride strongly enhances the glucose-lowering effect in triple oral antidiabetes therapy with sitagliptin and metformin for Japanese patients with type 2 diabetes mellitus.
Arai K, Maeda H, Sirabe S, Yamamoto R, Yamauchi M, Hirao T, Hirao S, Hirao K. Arai K, et al. Among authors: hirao k, hirao t, hirao s. Diabetes Technol Ther. 2013 Apr;15(4):335-41. doi: 10.1089/dia.2012.0287. Epub 2013 Mar 12. Diabetes Technol Ther. 2013. PMID: 23480592 Clinical Trial.
Six-month multicentric, open-label, randomized trial of twice-daily injections of biphasic insulin aspart 30 versus multiple daily injections of insulin aspart in Japanese type 2 diabetic patients (JDDM 11).
Hirao K, Arai K, Yamauchi M, Takagi H, Kobayashi M; Japan Diabetes Clinical Data Management Study Group. Hirao K, et al. Diabetes Res Clin Pract. 2008 Jan;79(1):171-6. doi: 10.1016/j.diabres.2007.08.011. Epub 2007 Oct 24. Diabetes Res Clin Pract. 2008. PMID: 17919762 Clinical Trial.
Both glimepiride and high-dose metformin are important for sustained glucose lowering in Japanese type 2 diabetes patients on glimepiride-sitagliptin-metformin therapy: subanalysis of a single-center, open-label, randomized study.
Arai K, Maeda H, Shirabe S, Yamamoto R, Kumakura A, Yamauchi M, Hirao T, Hirao S, Hirao K. Arai K, et al. Among authors: hirao k, hirao t, hirao s. Diabetes Technol Ther. 2014 Jul;16(7):442-6. doi: 10.1089/dia.2013.0310. Epub 2014 Feb 14. Diabetes Technol Ther. 2014. PMID: 24528246 Clinical Trial.
Present status of insulin therapy for type 2 diabetes treated by general practitioners and diabetes specialists in Japan: Third report of a cross-sectional survey of 15,652 patients.
Arai K, Takai M, Hirao K, Matsuba I, Matoba K, Takeda H, Kanamori A, Yamauchi M, Mori H, Terauchi Y. Arai K, et al. Among authors: hirao k. J Diabetes Investig. 2012 Aug 20;3(4):396-401. doi: 10.1111/j.2040-1124.2012.00198.x. J Diabetes Investig. 2012. PMID: 24843596 Free PMC article.
951 results